144 related articles for article (PubMed ID: 32279997)
21. Pin1 Exacerbates Non-Alcoholic Fatty Liver Disease by Enhancing Its Activity through Binding to ACC1.
Jin Y; Shangguan Z; Pang J; Chen Y; Lin S; Liu H
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892011
[TBL] [Abstract][Full Text] [Related]
22. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
23. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
[TBL] [Abstract][Full Text] [Related]
24. Genistein has beneficial effects on hepatic steatosis in high fat-high sucrose diet-treated rats.
Liu H; Zhong H; Yin Y; Jiang Z
Biomed Pharmacother; 2017 Jul; 91():964-969. PubMed ID: 28514835
[TBL] [Abstract][Full Text] [Related]
25. [Mechanism of Biejiajian Pills against non-alcoholic steatohepatitis based on lipidomics].
Huang J; Wang ML; Zhou ZY; Yan T; Xiong H; Mei ZN
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2557-2565. PubMed ID: 38812156
[TBL] [Abstract][Full Text] [Related]
26. Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
Li M; Ye T; Wang XX; Li X; Qiang O; Yu T; Tang CW; Liu R
PLoS One; 2016; 11(3):e0152085. PubMed ID: 27002331
[TBL] [Abstract][Full Text] [Related]
27. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
28. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway.
Shi C; Xue W; Han B; Yang F; Yin Y; Hu C
Eur J Pharmacol; 2019 May; 850():15-22. PubMed ID: 30753863
[TBL] [Abstract][Full Text] [Related]
29. Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of
Lee DE; Lee SJ; Kim SJ; Lee HS; Kwon OS
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717261
[TBL] [Abstract][Full Text] [Related]
30. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
[TBL] [Abstract][Full Text] [Related]
31. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
32. Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease.
Zhang H; Yang L; Wang Y; Huang W; Li Y; Chen S; Song G; Ren L
Life Sci; 2020 Sep; 257():118090. PubMed ID: 32679144
[TBL] [Abstract][Full Text] [Related]
33. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.
Xiao Z; Chu Y; Qin W
Life Sci; 2020 Sep; 256():117997. PubMed ID: 32585242
[TBL] [Abstract][Full Text] [Related]
34. Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH.
Tran M; Lee SM; Shin DJ; Wang L
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093267
[TBL] [Abstract][Full Text] [Related]
35. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway.
Yao H; Tao X; Xu L; Qi Y; Yin L; Han X; Xu Y; Zheng L; Peng J
Pharmacol Res; 2018 May; 131():51-60. PubMed ID: 29574225
[TBL] [Abstract][Full Text] [Related]
36. Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathway.
Wu C; Jing M; Yang L; Jin L; Ding Y; Lu J; Cao Q; Jiang Y
Chem Biol Interact; 2018 Aug; 291():111-119. PubMed ID: 29883724
[TBL] [Abstract][Full Text] [Related]
37. Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.
Chen HL; Tsai TC; Tsai YC; Liao JW; Yen CC; Chen CM
Nutr Diabetes; 2016 Dec; 6(12):e237. PubMed ID: 27941940
[TBL] [Abstract][Full Text] [Related]
38. Conophylline inhibits non-alcoholic steatohepatitis in mice.
Nakade Y; Sakamoto K; Yamauchi T; Inoue T; Kobayashi Y; Yamamoto T; Ishii N; Ohashi T; Sumida Y; Ito K; Nakao H; Fukuzawa Y; Umezawa K; Yoneda M
PLoS One; 2017; 12(6):e0178436. PubMed ID: 28594915
[TBL] [Abstract][Full Text] [Related]
39. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ
World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220
[TBL] [Abstract][Full Text] [Related]
40. Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice.
Inamdar S; Joshi A; Malik S; Boppana R; Ghaskadbi S
Biochem Biophys Res Commun; 2019 Oct; 519(1):106-112. PubMed ID: 31472955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]